Similar articles

• [Anti-immunoglobulin antibodies in immunologically deficient patients. Value of their determination in intolerance reactions to therapeutic gamma globulin injections].

  Caldera LH, Ropars C, Griscelli C, Homberg JC, Salmon C. Caldera LH, et al. Rev Fr Transfus. 1973 Dec;16(4):393-402. doi: 10.1016/s0035-2977(73)80048-3. Rev Fr Transfus. 1973. PMID: 4135408 French. No abstract available.
• [Adverse effects of an injection of anti-Rh gamma-globulin due to the presence of anti-gamma A antibodies].

  Rivat L, Rivat C, Parent M, Ropartz C. Rivat L, et al. Presse Med (1893). 1970 Nov 7;78(47):2072. Presse Med (1893). 1970. PMID: 4098405 French. No abstract available.
• Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin.

  Ferreira A, Garcia Rodriguez MC, Lopez-Trascasa M, Pascual Salcedo D, Fontan G. Ferreira A, et al. Clin Immunol Immunopathol. 1988 May;47(2):199-207. doi: 10.1016/0090-1229(88)90072-4. Clin Immunol Immunopathol. 1988. PMID: 2450712
• Treatment of antibody deficiency syndromes with subcutaneous infusion of gamma globulin.

  Roord JJ, van der Meer JW, Kuis W, van Furth R. Roord JJ, et al. Birth Defects Orig Artic Ser. 1983;19(3):217-21. Birth Defects Orig Artic Ser. 1983. PMID: 6197108 Review. No abstract available.
• The gamma globulins. IV. Therapeutic uses of gamma globulin.

  Janeway CA, Rosen FS. Janeway CA, et al. N Engl J Med. 1966 Oct 13;275(15):826-31. doi: 10.1056/NEJM196610132751508. N Engl J Med. 1966. PMID: 4161939 Review. No abstract available.